The global integrin beta market is anticipated to grow at a considerable CAGR of around 6.5%during the forecast years. The increase in cancer cases all over the globe is driving the integrin beta market due to its increase the demand for integrin beta is also been increasing. For instance, As per the data released by International Agency for Research on Cancer (IARC), in 2018, there were 17.0 million new cancer cases and 9.5 million cancer deaths across the globe. The global burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. For instance, according to the American Cancer Society, in 2021, 1,898,160 new cancer cases and 608,570 cancer deaths are expected to occur in the United States. In contrast, by 2020, an estimated 1,806,590 young people were diagnosed with cancer in the United States, and 606,520 people died from the disease.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/integrin-beta-market
In February 2020, According to a report published by World Health Organization (WHO), Cancer is a leading cause of death across the globe, nearly 10 million deaths in 2020 were observed. Moreover, approximately 400 000 children develop cancer each year. The most common cancers are breast, lung, colon and rectum, and prostate cancers. Integrin beta combines with different ? subunits, including ?4, ?5, and ?2, to affect the characteristics of cancer cells, and the progression of tumors, and its primary function is to form focal adhesion between cancer cells and ECM owing to such factors the cell mutation can be stopped with integrin beta that in turn is augmenting the market to grow.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- AstraZeneca, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Novartis International AG, Pfizer Inc., and Others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Integrin Beta Market Report Segment
By Type
- IGBT 1
- IGBT 2
- IGBT 3
- IGBT 4
- IGBT 5
- IGBT 6
- IGBT 7
- IGBT 8
By Application
- Genetic Disorder
- CVD
- Cancer
- Others
A full report of Integrin Beta Market is available at: https://www.omrglobal.com/industry-reports/integrin-beta-market
Integrin Beta Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abbott Laboratories
- Avipero
- Biogen Inc.
- Bristol Myers Squibb (BMS)
- Clanotech AB
- Corbus Pharmaceuticals, Inc.
- GlaxoSmithKline plc
- Idera Pharmaceuticals, Inc.
- Merck Group
- Morphic Therapeutic
- Neovacs
- Octapharma AG
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
